Malaria vaccines

Frontiers in Bioscience

Volumn 12, Issue 10, 2007, Pages 3928-3955

  Komisar, Jack L ^a  

^a Institute of Research   (United States)

Author keywords

Clinical trials; Immunity; Malaria; Plasmodium falciparum; Review; Vaccine

Indexed keywords

ANIMALIA; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PLASMODIUM YOELII YOELII;

MALARIA VACCINE; RECOMBINANT VACCINE;

ANIMAL; ANIMAL MODEL; GENOMICS; IMMUNOLOGY; INNATE IMMUNITY; PROTEOMICS; REVIEW;

ANIMALS; GENOMICS; IMMUNITY, NATURAL; MALARIA VACCINES; MODELS, ANIMAL; PROTEOMICS; VACCINES, SYNTHETIC;

EID: 34347236513     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2361     Document Type: Article

References (237)

1. Greenwood B. M., K. Bojang, C. J. M. Whitty & G. A. T. Targett: Malaria. Lancet 365, 1487-1498 (2005) (Pubitemid 40591695)
2. Breman, J. G, M. S. Alilio & A. Mills: Conquering the intolerable burden of malaria: What's new, what's needed: A summary. Amer J Trop Med Hyg 71(Suppl 2), 1-15 (2004) (Pubitemid 39127486)
3. Klausner, R. & P. Alonso: Malaria. An attack on all fronts. Nature 430, 930-931 (2004)
4. Ballou, W. R.: Malaria vaccines in development. Expert Opin Emerg Drugs 10, 489-503 (2005) (Pubitemid 41176283)
5. Suh, K. N., K. C. Kain & J. S. Keystone: Malaria. Can Med Assoc J 170, 1693-1702 (2004) (Pubitemid 38758748)
6. Ballou, W. R., M. Arevalo-Herrera, D. Carucci, T. L. Richie, G. Corradin, C. Diggs, P. Druilhe, B. K. Giersing, A. Saul, D. G. Heppner, K. E. Kester, D. E. Lanar, J. Lyon, A. V. S. Hill, W. Pan & J. D. Cohen: Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg 71(Suppl 2), 239-247 (2004) (Pubitemid 39121328)
7. th ed. Eds: Warrell, DA, Gilles, HM, Arnold, London, U. K. 8-34 (2002)
8. Florens, L., M. P. Washburn, J. D. Raine, R. M. Anthony, M. Grainger, J. D. Haynes, J. K. Moch, N. Muster, J. B. Sacci, D. L. Tabb, A. A. Witney, D. Wolters, Y. Wu, M. J. Gardner, A. A. Holder, R. E. Sinden, J. R. Yates & D. J. Carucci: A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520-526 (2002)
9. Rosenberg, R., R. A. Wirtz, I. Schneider & R. Burge: An estimation of the number of malaria sporozoites ejected by a feeding mosquito. Trans R Soc Trop Med Hyg 84, 209-212 (1990) (Pubitemid 20172004)
10. Ponnudurai, T., A. H. W. Lensen, G. J. A. Van Gemert, M. G. Bolmer & J. H. E. T. Meuwissen. Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. Trans R Soc Trop Med Hyg 85, 175-180 (1991)
11. Amino, R., S. Thiberge, B. Martin, S. Celli, S. Shorte, F. Frischknecht & R. Ménard: Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med 12, 220-224 (2006) (Pubitemid 43214749)
12. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.-J. Liu, B. Pulendran & K. Palucka: Immunobiology of dendritic cells. Annu Rev Immunol. 18, 767-811 (2000) (Pubitemid 30365397)
13. Stevenson, M. M. & E. M. Riley. Innate immunity to malaria. Nat Rev Immunol 4, 169-180 (2004) (Pubitemid 38339083)
14. Urban, BC, R Ing & MM Stevenson: Early interactions between blood-stage Plasmodium parasites and the immune system. In: Current topics in microbiology and immunology Vol. 297. Immunology and immunopathogenesis of malaria. Ed: Langhorne J, Springer-Verlag, Berlin and Heidelberg, Germany, 25-70 (2005) (Pubitemid 41383377)
15. Pichyangkul, S., K. Yongvanitchit, U. Kum-arb, H. Hemmi, S. Akira, A. M. Krieg, D. G. Heppner, V. A. Stewart, H. Hasegawa, S. Looareesuwan, G. D. Shanks & R. S. Miller: Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 172, 4926-4933 (2004) (Pubitemid 38456417)
16. Mohan, K., P. Moulin & M. M. Stevenson: Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol 159, 4990-4998 (1997) (Pubitemid 127471037)
17. Hollingdale, MR & U Krzych: Immune response to liver-stage parasites: Implications for vaccine development. In: Malaria immunology. Chem Immunol Vol. 80. Eds: Perlmann P, Troye-Blomberg M, Karger, Basel, Switzerland, 97-124 (2002) (Pubitemid 34516795)
18. Walther, M., J. Woodruff, F. Edele, D. Jeffries, J. E. Tongren, E. King, L. Andrews, P. Bejon, S. C. Gilbert J. B. De Souza, R. Sinden, A. V.. S Hill & E. M. Riley: Innate immune responses to human malaria: Heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol 177, 5736-5745 (2006) (Pubitemid 44527649)
19. Baratin, M., S. Roetynck, C. Lépolard, C. Falk, S. Sawadogo, S. Uematsu, S. Akira, B. Ryffel, J.-G. Tiraby, L. Alexopoulou, C. J. Kirschning, G. Gysin, E. Vivier & S. Ugolini: Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci USA 102, 14747-14752 (2005) (Pubitemid 41457127)
20. Troye-Blomberg, M., S. Worku, P. Tangteerawatana, R. Jamshaid, K. Söderström, G. Elghazali, L. Moretta, M.-L. Hammarström & I. Mincheva-Nilsson: Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Scand J Immunol 50, 642-650 (1999)
21. Engwerda, C. R. & M. F. Good. Interactions between malaria parasites and the host immune system. Curr Opin Immunol 17, 1-7 (2005)
22. Snow, R. W. & K. Marsh. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 52, 235-264 (2002) (Pubitemid 36069925)
23. Snow, R. W., M. Craig, U. Deichmann & K. Marsh: Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ 77, 624-640 (1999) (Pubitemid 29446615)
24. Duffy, P. E. & M. Fried: Malaria during pregnancy: parasites, antibodies and chondroitin sulphate A. Biochem Soc Trans 27, 478-482 (1999) (Pubitemid 29412472)
25. Smith, J. D. & K. W. Deitsch. Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines. J Exp Med 200, 1093-1097 (2004) (Pubitemid 39507048)
26. Struik, S. S. & E. M. Riley: Does malaria suffer from lack of memory? Immunol Rev 201, 268-290 (2004) (Pubitemid 39318458)
27. Roshanravan, B., E. Kari, R. H. Gilman, L. Cabrera, E. Lee, J. Metcalfe, M. Calderon, A. G. Lescano, S. H. Montenegro, C. Calampa & J. M. Vinetz: Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg 69, 45-52 (2003)
28. Owusu-Agyei, S., K. A. Koram, J. K. Baird, G. C. Utz, F. N. Binka, F. K. Nkrumah, D. J. Fryauff & S. L. Hoffman: Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg 65, 197-203 (2001) (Pubitemid 32847811)
29. Sergent, E. & E. Sergent. History of the concept of "relative immunity" or "premunition" correlated to latent infection. Indian J Malariol 10, 53-80 (1956)
30. Landau, I & P Gautret: Animal models: rodents. In: Malaria. Parasite biology, pathogenesis, and protection Ed: Sherman, I. W. ASM Press, Washington, DC, 401-417 (1998)
31. Langhorne, J., S. J. Quin & L. A. Sanni: Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol 8, 204-228 (2002) (Pubitemid 34516800)
32. Gysin, J: Animal models: primates. In: Malaria. Parasite biology, pathogenesis, and protection Ed: Sherman, I. W. ASM Press, Washington, DC, 419-441 (1998)
33. Cohen, S.: Progress in malaria vaccine development. Brit Med Bull 38, 161-165 (1982) (Pubitemid 12008186)
34. Pico de Coaña, Y., J. Rodríguez, E. Guerrero, C. Barrero, R. Rodríguez, M. Mendoza & M. A. Patarroyo: A highly infective Plasmodium vivax strain adapted to Aotus monkeys: Quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development. Vaccine 21, 3930-3937 (2003) (Pubitemid 37338220)
35. Stewart, V. A.: Plasmodium vivax under the microscope: the Aotus model. Trends Parasitol 19, 589-594 (2003) (Pubitemid 37464808)
36. Herrera, S., B. L. Perlaza, A. Bonelo & M. Arévalo-Herrera: Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int J Parasitol 32, 1625-1635 (2002) (Pubitemid 35336004)
37. Collins, W. E., J. S. Sullivan, A. Williams, D. Nace, T. Williams, G. G. Galland & J. W. Barnwell: Aotus nancymaae as a potential model for the testing of antisporozoite and liver stage vaccines against Plasmodium falciparum. Am J Trop Med Hyg 74, 422-424 (2006) (Pubitemid 46774363)
38. Stowers, A. W., M. C. Kennedy, B. P. Keegan, A. Saul, C. A. Long & L. H. Miller: Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. Infect Immun 70, 6961-6967 (2002) (Pubitemid 35387931)
39. Daubersies, P., A. W. Thomas, P. Millet, K. Brahimi, J. A. M. Langermans, B. Ollomo, L. Ben Mohamed, B. Slierendregt, W. Eling, A. Van Belkum, G. Dubreuil, J. F. G. M. Meis, C. Guérin-Marchand, S. Cayphas, J. Cohen, H. Gras-Masse & P. Druilhe: Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liverstage antigen 3. Nat Med 6, 1258-1263 (2000)
40. Stowers, A. W. & L. H. Miller: Are trials in New World monkeys on the critical path for blood-stage malaria vaccine development? Trends Parasitol 17, 415-419 (2001) (Pubitemid 32800657)
41. Heppner, D. G., J. F. Cummings, C. Ockenhouse, K. E. Kester, J. A. Lyon & D. M. Gordon: New World monkey efficacy trials for malaria vaccine development: critical path or detour? Trends Parasitol 17, 419-425 (2001) (Pubitemid 32800658)
42. Good, M. F. & D. L. Doolan: Immune effector mechanisms in malaria. Curr Opin Immunol 11, 412-419 (1999) (Pubitemid 29377908)
43. U Krzych, & RJ Schwenk: The dissection of CD8 T cells during liver-stage infection. In: Immunology and immunopathogenesis of Malaria Ed: Langhorne J, Springer-Verlag, Berlin and Heidelberg, Germany 1-24 (2005) (Pubitemid 41383376)
44. Krzych, U., R. Schwenk, M. Guebre-Xabier, P. Sun, D. Palmer, K. White & I. Chalom: The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol Rev 174, 123-134 (2000) (Pubitemid 30201384)
45. Walther, M.: Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria. Expert Rev Vaccines 5, 81-93 (2006)
46. Hill, A. V. S.: Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol 6, 21-32 (2006) (Pubitemid 43279750)
47. Garcia, J. E., A. Puentes & M. E. Patarroyo: Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: Implications for vaccine design. Clin Microbiol Rev 19, 686-707 (2006) (Pubitemid 44582977)
48. Greenwood, B., and P. Alonso: Malaria vaccine trials. Chem Immunol 80, 366-395 (2002) (Pubitemid 34516809)
49. Stoute, J. A., M. Slaoui, D. G. Heppner, P. Momin, K. E. Kester, P. Desmons, B. T. Wellde, N. Garçon, U. Krzych, M. Marchand, W. R. Ballou & J. D. Cohen for the RTS, S Malaria Vaccine Evaluation Group: A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 336, 86-91 (1997) (Pubitemid 27020884)
50. Rogers, WO & SL Hoffman: Malaria vaccines. In: Malaria. Molecular and clinical aspects Eds: Wahlgren M, Perlmann P. Harwood Academic Publishers. Amsterdam, Netherlands 439-493 (1999)
51. Schofield, L., A. Ferreira, R. Altszuler, V. Nussenzweig & R. S. Nussenzweig: Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol 139, 2020-2025 (1987) (Pubitemid 17141640)
52. Favre, N., B. Ryffel, G. Bordmann & W. Rudin: The course of Plasmodium chabaudi chabaudi infections in interferon-gamma receptor deficient mice. Parasite Immunol 19, 375-383 (1997) (Pubitemid 27373594)
53. Luty, A. J. F., B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, F. Migot-Nabias, P. Deloron, R. S. Nussenzweig & P. G. Kremsner: Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179, 980-988 (1999) (Pubitemid 29159345)
54. Hermsen, C. C., D. F. Verhage, D. S. C. Telgt, K. Teelen, J. T. Bousema, M. Roestenberg, A. Bolad, K. Berzins, G. Corradin, O. Leroy, M. Theisen & R. W. Sauerwein: Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial. Vaccine doi:10.1016/j.vaccine.2006.06.081 (2006)
55. Alonso, P. L., J. Sacarlal, J. J. Aponte, A. Leach, E. Macete, J. Milman, I. Mandomando, B. Spiessens, C. Guinovart, M. Espasa, Q. Bassat, P. Aide, O. Ofori-Anyinam, M. M. Navia, S. Corachan, M. Ceuppens, M.-C. Dubois, M.-A. Demoitié, F. Dubovsky, C. Menéndez, N. Tornieporth, W. R. Ballou, R. Thompson & J. Cohen: Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364, 1411-1420 (2004) (Pubitemid 39370716)
56. Graves, P., H. Gelband & P. Garner. The SPf66 malaria vaccine: What is the evidence for efficacy? Parasitol Today 14, 218-220 (1998)
57. Nussenzweig, R. S., J. Vanderberg, H. Most & C. Orton: Protective immunity produced by the injection of xirradiated sporozoites of Plasmodium berghei. Nature 216, 160-162 (1967)
58. Hoffman, S. L., L. M. L. Goh, T. C. Luke, I. Schneider, T. P. Le, D. L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, D. M. Gordon, J. A. Stoute, L. W. Preston Church, M. Sedegah, D. G. Heppner, W. R. Ballou & T. L. Richie: Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185, 1155-1164 (2002) (Pubitemid 34297774)
59. Taylor-Robinson, A. W.: Vaccination against malaria: Targets, strategies and potentiation of immunity to bloodstage parasites. Frontiers Biosci 5, e16-29 (2000)
60. Butler, D.: Mosquito production mooted as fast track to malaria vaccine. Nature 425, 437 (2003) (Pubitemid 37237011)
61. Cheng, Q., G. Lawrence, C. Reed, A. Stowers, L. Ranford-Cartwright, A. Creasey, & A. Saul: Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am J Trop Med Hyg 57, 495-500 (1997) (Pubitemid 27439125)
62. Matuschewski, K.: Vaccine development against malaria. Curr Opin Immunol 18, 1-9 (2006)
63. Greenwood, B: What can be expected from malaria vaccines? In: Malaria vaccine development: A multiimmune response approach Ed: Hoffman SL, ASM Press, Washington, DC, 277-299 (1996)
64. Tsuji, M. & F. Zavala: T cells as mediators of protective immunity against liver stages of Plasmodium. Trends Parasitol 19, 88-93 (2003) (Pubitemid 36173891)
65. Moreno, A., P. Clavijo, R. Edelman, J. Davis, M. Sztein, D. Herrington & E. Nardin: Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int Immunol 3, 997-1003 (1991)
66. Tsuji, M., P. Romero, R. S. Nussenzweig & F. Zavala: CD4+ cytolytic T cell clone confers protection against murine malaria. J Exp Med 172, 1353-1357 (1990) (Pubitemid 20366210)
67. Doolan, D. L., J. C. Aguiar, W. R. Weiss, A. Sette, P. L. Felgner, D. P. Regis, P. Quinones-Casas, J. R. Yates, P. L. Blair, T. L. Richie, S. L. Hoffman & D. J. Carucci: Utilization of genomic sequence information to develop malaria vaccines. J Exp Biol 206, 3789-3802 (2003) (Pubitemid 37365461)
68. Mueller, A.-K., M. Labaied, S. H. I. Kappe & K. Matuschewski: Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433, 164-167 (2005)
69. Ménard, R.: Knockout malaria vaccine? Nature 433, 113-114 (2005)
70. Heppner, D. G., K. E. Kester, C. F. Ockenhouse, N. Tornieporth, O. Ofori, J. A. Lyon, V. A. Stewart, P. Dubois, D. E. Lanar, U. Krzych, P. Moris, E. Angov, J. F. Cummings, A. Leach, B. T. Hall, S. Dutta, R. Schwenk, C. Hillier, A. Barbosa, L. A. Ware, L. Nair, C. A. Darko, M. R. Withers, B. Ogutu, M. E. Polhemus, M. Fukuda, S. Pichyangkul, M. Gettayacamin, C. Diggs, L. Soisson, J. Milman, M.-C. Dubois, N. Garçon, K. Tucker, J. Wittes, C. V. Plowe, M. A. Thera, O. K. Duombo, M. G. Pau, J. Goudsmit, W. R. Ballou & J. Cohen: Towards an RTS, S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 23, 2243-2250 (2005) (Pubitemid 40341460)
71. Gordon, D. M., T. W. McGovern, U. Krzych, J. C. Cohen, I. Schneider, R. LaChance, D. G. Heppner, G. Yuan, M. Hollingdale, M. Slaoui, P. Hauser, P. Voet, J. C. Sadoff & W. R. Ballou: Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis 171, 1576-1585 (1995).
72. nd ed. Geneva, World Health Organization. http://mosquito.who.int/docs/hbsm.pdf (accessed by Alonso et al. on Sept 28, 2004)
73. Alonso, P. L., J. Sacarlal, J. J. Aponte, A. Leach, E. Macete, P. Aide, B. Sigauque, J. Milman, I. Mandomando, Q. Bassat, C. Guinovart, M. Espasa, S. Corachan, M. Lievens, M. M. Navia, M.-C. Dubois, C. Menendez, F. Dubovsky, J. Cohen, R. Thompson & W. R. Ballou: Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 366, 2012-2018 (2005) (Pubitemid 41773376)
74. Schwenk, R., L. V. Asher, I. Chalom, D. Lanar, P. Sun, K. White, D. Keil, K. E. Kester, J. Stoute, D. G. Heppner & U. Krzych: Opsonization by antigen-specific antibodies as a mechanism of protective immunity induced by Plasmodium falciparum circumsporozoite protein-based vaccine. Parasite Immunol 25, 17-25 (2003) (Pubitemid 38019095)
75. Sun, P., R. Schwenk, K. White, J. A. Stoute, J. Cohen, W. R. Ballou, G. Voss, K. E. Kester, D. G. Heppner & U. Krzych: Protective immunity induced with malaria vaccine, RTS, S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma. J Immunol 171, 6961-6967 (2003) (Pubitemid 37532133)
76. Walsh, D. S., M. Gettayacamin, W. W. Leitner, J. A. Lyon, V. A. Stewart, G. Marit, S. Pichyangkul, P. Gosi, P. Tongtawe, K. E. Kester, C. A. Holland, N. Kolodny, J. Cohen, G. Voss, W. R. Ballou & D. G. Heppner: Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS, S/AS02A. Vaccine 24, 4167-4178 (2006) (Pubitemid 44308225)
77. Stewart, V. A., S. M. McGrath, S. Davis, A. S. Hess, L. A. Ware, K. E. Kester, J. F. Cummings, J. R. Burge, G. Voss, M. Delchambre, N. Garçon, J. D. Cohen, D. B. Tang, D. S. Walsh & D. G. Heppner: Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS, S/AS02A. Vaccine 24, 6483-6492 (2006) (Pubitemid 44511857)
78. Stewart, V. A., D. S. Walsh, S. M. McGrath, K. E. Kester, J. F. Cummings, G. Voss, M. Delchambre, N. Garçon, J. D. Cohen & D. G. Heppner: Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS, S in rhesus macaques. Vaccine 24, 6493-6502 (2006) (Pubitemid 44511858)
79. Graves, P. & H. Gelband: Vaccines for preventing malaria (pre-erythrocytic). Cochrane Database Systematic Reviews, Cochrane Library, Vol. 4 (2006)
80. Dovi, E.: Ghana's Malaria Problem Gets Boost From Vaccine Trials. VOA News 10 October 2006
81. Hedstrom, R. C., J. R. Campbell, M. L. Leef, Y. Charoenvit, M. Carter, M. Sedegah, R. L. Beaudoin & S. L. Hoffman: A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull WHO 68(Suppl), 152-157 (1990)
82. Rogers, W. O., A. Malik, S. Mellouk, K. Nakamura, M. D. Rogers, A. Szarfman, D. M. Gordon, A. K Nussler, M. Aikawa & S. L. Hoffman: Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci USA 89, 9176-9180 (1992)
83. Sultan, A. A., V. Thathy, U. Frevert, K. J. H. Robson, A. Crisanti, V. Nussenzweig, R. S. Nussenzweig & R. Ménard: TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell 90, 511-522 (1997) (Pubitemid 27347241)
84. Khusmith, S., Y. Charoenvit, S. Kumar, M. Sedegah, R. L. Beaudoin and S. L. Hoffman: Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252, 715-718 (1991) (Pubitemid 21917001)
85. Schneider, J., S. C. Gilbert, T. J. Blanchard, T. Hanke, K. J. Robson, C. M. Hannan, M. Becker, R. Sinden, G. L. Smith & A. V. S. Hill: Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4, 397-402 (1998) (Pubitemid 28212753)
86. Müller, H.-M., I. Reckmann, M. R. Hollingdale, H. Bujard, K. J. H. Robson & A. Crisanti: Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J 12, 2881-2889 (1993) (Pubitemid 23218338)
87. Walsh, D. S., S. Pichyangkul, M. Gettayacamin, P. Tongtawe, C.-A. Siegrist, P. Hansukjariya, K. E. Kester, C. A. Holland, G. Voss, J. Cohen, A. V. Stewart, R. S. Miller, W. R. Ballou & D. G. Heppner: Safety and immunogenicity of RTS, S+ TRAP malaria vaccine, formulated in the AS02A adjuvant system, in infant rhesus monkeys. Amer J Trop Med Hyg 70, 499-509 (2004) (Pubitemid 38658143)
88. McConkey, S. J., W. H. H. Reece, V. S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J. M. Vuola, T. J. Blanchard, P. Gothard, K. Watkins, C. M. Hannan, S. Everaere, K. Brown, K. E. Kester, J. Cummings, J. Williams, D. G. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M. T. M. Roberts, M. Roy, G. L. Smith, J. Schneider, T. Peto, R. E. Sinden, S. C. Gilbert & A. V. S. Hill. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 9, 729-735 (2003) (Pubitemid 36749222)
89. Dunachie, S. J., M. Walther, J. E. Epstein, S. Keating, T. Berthoud, L. Andrews, R. F. Andersen, P. Bejon, N. Goonetilleke, I. Poulton, D. P. Webster, G. Butcher, K. Watkins, R. E. Sinden, G. L. Levine, T. L. Richie, J. Schneider, D. Kaslow, S. C. Gilbert, D. J. Carucci & A. V. S. Hill: A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin- related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naïve adults against Plasmodium falciparum sporozoite challenge. Infect Immun 74, 5933-5942 (2006) (Pubitemid 44484581)
90. Moorthy, V. S., E. B. Imoukhuede, P. Milligan, K. Bojang, S. Keating, P. Kaye, M. Pinder, S. C. Gilbert, G. Walraven, B. M. Greenwood & A. V. S. Hill: A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. PLoS Medicine 1, 128-136 (2004) (Pubitemid 40412716)
91. Hollingdale, M. R., C. J. McCormick, K. G. Heal, A. W. Taylor-Robinson, P. Reeve, R. Boykins & J. W. Kazura. Biology of malarial liver stages: implications for vaccine design. Ann Trop Med Parasitol 92, 411-417 (1998) (Pubitemid 28312557)
92. Morrot, A. & F. Zavala: Effector and memory CD8+ T cells as seen in immunity to malaria. Immunol Rev 201, 291-303 (2004) (Pubitemid 39318459)
93. Todryk, S. M. & M. Walther: Building better T-cellinducing malaria vaccines. Immunology 115, 163-169 (2005) (Pubitemid 40733401)
94. White, K. L., H. L. Snyder & U. Krzych: MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol 156, 3374-3381 (1996) (Pubitemid 26123553)
95. Weiss, W. R., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller & S. L. Hoffman: Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 171, 763-773 (1990) (Pubitemid 20088980)
96. Renggli, J., M. Hahne, H. Matile, B. Betschart, J. Tschopp & G. Corradin: Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforinmediated cytotoxicity. Parasite Immunol 19, 145-148 (1997) (Pubitemid 27138288)
97. Weiss, W. R., M. Sedegah, R. L. Beaudoin, L. H. Miller & M. F. Good: CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci 85, 573-576 (1988) (Pubitemid 18059317)
98. Hill, A. V., C. E. Alsopp, D. Kwiatkowski, N. M. Anstey, P. Twumasi, P. A. Rowe, S. Bennett, D. Brewster, A. J. McMichael & B. M. Greenwood: Common west African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600 (1991) (Pubitemid 21912384)
99. Anstey, N. M., J. B. Weinberg, M. Y. Hassanali, E. D. Mwaikambo, D. Manyenga, M. A. Misukonis, D. A. Arnelle, D. Hollis, M. I. McDonald & D. L. Granger: Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184, 557-567 (1996) (Pubitemid 26324109)
100. Pombo, D. J., G. Lawrence, C. Hirunpetcharat, C. Rzepczyk, M. Bryden, N. Cloonan, K. Anderson, Y. Mahakunkijcharoen, L. B. Martin, D. Wilson, S. Elliott, S. Elliott, D. P. Eisen, J. B. Weinberg, A. Saul & M. F. Good: Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360, 610-617 (2002) (Pubitemid 35232195)
101. Wang, R., T. L. Richie, M. F. Baraceros, N. Rahardjo, T. Gay, J.-G. Banania, Y. Charoenvit, J. E. Epstein, T. Luke, D. A. Freilich, J. Norman & S. L. Hoffman: Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Infect Immun 73, 2863-2872 (2005) (Pubitemid 40570355)
102. Guerin-Marchand, C., P. Druilhe, B. Galey, A. Londono, J. Patarapotikul, R. L. Beaudoin, C. Dubeaux, A. Tartar, O. Mercerau-Puijalon, & G. Langsley: A liverstage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329, 164-167 (1987) (Pubitemid 17125254)
103. Zhu, J., & M. R. Hollingdale: Structure of Plasmodium falciparum liver stage antigen-1. Mol Biochem Parasitol 48, 223-226 (1991)
104. Hillier, C. L., L. A. Ware, A. Barbosa, E. Angov, J. A. Lyon, D. G. Heppner & D. E Lanar: Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Infect Immun 73, 2109-2115 (2005) (Pubitemid 40470809)
105. Kurtis, J. D., M. R. Hollingdale, A. J. F. Luty, D. E. Lanar, U. Krzych & P. E. Duffy: Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Trends Parasitol 17, 219-223 (2001) (Pubitemid 32422165)
106. Lee, H.-W., S.-U. Moon, H.-S. Ryu, Y.-J. Kim, S.-H. Cho, G.-T. Chung, K. Lin, B.-K. Na, Y. Kong, K-S. Chung & T.-S. Kim: Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection. Korean J Parasitol 44, 49-54 (2006)
107. Good, M. F., H. Xu, M. Wykes & C. R. Engwerda: Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Ann Rev Immunol 23, 69-99 (2005) (Pubitemid 40563165)
108. Bojang, K. A., P. J. M. Milligan, M. Pinder, L. Vigneron, A. Alloueche, K. E. Kester, W. R. Ballou, D. J. Conway, W. H. H. Reece, P. Gothard, L. Yamuah, M. Delchambre, G. Voss, B. M. Greenwood, A. Hill, K. P. W. J. McAdam, N. Tornieporth, J. D. Cohen & T. Doherty: Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune men in The Gambia: a randomised trial. Lancet 358, 1927-1934 (2001) (Pubitemid 34072872)
109. Cavanagh, D. R., D. Dodoo, L. Hviid, J. A. L. Kurtzhals, T. G. Theander, B. D. Akanmori, S. Polley, D. J. Conway, K. Koram & J. S. McBride: Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun 72, 6492-6502 (2004) (Pubitemid 39425430)
110. JD Haynes, JK Moch & DS Smoot: Erythrocytic malaria growth or invasion inhibition assays with emphasis on suspension culture GIA. In: Methods in molecular medicine, Vol. 72: Malaria methods and protocols. Ed: Doolan DL, Humana Press, Totowa, NJ, 535-554 (2002)
111. Giersing, B., K. Miura, R. Shimp, J. Wang, H. Zhou, A. Orcutt, A. Stowers, A. Saul, L. H. Miller, C. Long & S. Singh: Posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: Impact on functional immune responses to a malaria vaccine candidate. Infect Immun 73, 3963-3970 (2005) (Pubitemid 40923135)
112. Persson, K. E. M., C. T. Lee, K. Marsh & J. G. Beeson: Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies. J Clin Microbiol 44, 1665-1673 (2006) (Pubitemid 43726253)
113. Bergmann-Leitner, E. S., E. H. Duncan, G. E. Mullen, J. R. Burge, F. Khan, C. A. Long, E. Angov & J. A. Lyon: Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens. Am J Trop Med Hyg 75, 437-442 (2006) (Pubitemid 46941302)
114. Bouharoun-Tayoun, H., P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi & P. Druilhe: Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172, 1633-1641 (1990)
115. P Druilhe, & H Bouharoun-Tayoun: Antibodydependent cellular inhibition assay. In: Methods in molecular medicine, Vol. 72: Malaria methods and protocols. Ed: Doolan DL, Humana Press, Totowa, NJ, 529-534 (2002)
116. Giersing, B. K., F. Dubovsky, A. Saul, F. Denamur, P. Minor & B. Meade: Meeting report: Potency assay design for adjuvanted recombinant proteins as malaria vaccines. Vaccine 24, 4264-4270 (2006)
117. Su, Z. & M. M. Stevenson: Central role of endogenous gamma interferon in protective immunity against bloodstage Plasmodium chabaudi AS infection. Infect Immun 68, 4399-4406 (2000) (Pubitemid 30497704)
118. Hodder, A. N., P. E. Crewther, M. L. S. M. Matthew, G. E. Reid, R. L. Moritz, R. J. Simpson & R. F. Anders: The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 271, 29446-29452 (1996) (Pubitemid 26382664)
119. Peterson, M. G., V. M. Marshall, J. A. Smythe, P. E. Crewther, A. Lew., A. Silva, R. F. Anders & D. J. Kemp: Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol Cell Biol 9, 3151-3154 (1989) (Pubitemid 19163087)
120. Triglia, T., J. Healer, S. R. Caruana, A. N. Hodder, R. F. Anders, B. S. Crabb & A. F. Cowman: Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol Microbiol 38, 706-718 (2000)
121. Mitchell, G. H., A. W. Thomas, G. Margos, A. R. Dluzewski & L. H. Bannister: Apical membrane antigen-1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect Immun 72, 154-158 (2004) (Pubitemid 38018172)
122. Chesne-Seck, M.-L., J. C. Pizarro, B. Vulliez-Le Normand, C. R. Collins, M. J. Blackman, B. W. Faber, E. J. Remarque, C. H. M. Kocken, A. W. Thomas & G. A. Bentley: Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. Mol Biochem Parasitol 144, 55-67 (2005) (Pubitemid 41393370)
123. Dutta, S., J. D. Haynes, A. Barbosa, L. A. Ware, J. D. Snavely, J. K. Moch, A. W. Thomas & D. E. Lanar: Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum. Infect Immun 73, 2116-2122 (2005) (Pubitemid 40470810)
124. Narum, D. L., S. A. Ogun, A. W. Thomas & A. A. Holder: Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM bloodstage infection. Infect Immun 68, 2899-2906 (2000) (Pubitemid 30253870)
125. Malkin, E. M., D. J. Diemert, J. H. McArthur, J. R. Perreault, A. P. Miles, B. K. Giersing, G. E. Mullen, A. Orcutt, O. Muratova, M. Awkal, H. Zhou, J. Wang, A. Stowers, C. A. Long, S. Mahanty, L. H. Miller, A. Saul & A. P. Durbin: Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun 73, 3677-3685 (2005) (Pubitemid 40745912)
126. Graves, P. M., M. M. Levine, eds.: Battling Malaria: Strengthening the U. S. Military Malaria Vaccine Program National Academies Press, Washington, D. C., 2006.
127. Holder, A. A.: The precursor to major merozoite surface antigens: structure and role in immunity. Prog Allergy 41, 72-97 (1988)
128. McBride, J. S. & H.-G. Heidrich. Fragments of the polymorphic Mr 185 000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol Biochem Parasitol 23, 71-84 (1987) (Pubitemid 17034743)
129. Blackman, M. J., T. J. Scott-Finnigan, S. Shai & A. A. Holder: Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J Exp Med 180, 389-393 (1994) (Pubitemid 24181090)
130. Etlinger, H. M., P. Caspers, H. Matile, H.-J. Schönfeld, D. Stüber & B. Tacacs. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun 59, 3498-3503 (1991)
131. Siddiqui, W. A., L. Q. Tam, K. J. Kramer, G. S. N. Hui, S. E. Case, K. M. Yamaga, S. P. Chang, E. B. T. Chan & S.-C. Kan: Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci USA 84, 3014-3018 (1987) (Pubitemid 17064768)
132. AA Holder: Preventing merozoite invasion of erythrocytes. In: Malaria vaccine development: A multiimmune response approach Ed: Hoffman SL, ASM Press, Washington, DC, 77-104 (1996)
133. 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J Immunol 173, 666-672 (2004) (Pubitemid 38797397)
134. Corran, P. H., R. A. O'Donnell, J. Todd, C. Uthaipibull, A. A. Holder, B. S. Crabb & E. M. Riley: The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia. Infect Immun 72, 6185-6189 (2004) (Pubitemid 39303741)
135. Ockenhouse, C. F., E. Angov, K. E. Kester, C. Diggs, L. Soisson, J. F. Cummings, A. V. Stewart, D. R. Palmer, B. Mahajan, U. Krzych, N. Tornieporth, M. Delchambre, M. Vanhandenhove, O. Ofori-Anyinam, J. Cohen, J. A. Lyon & D. G. Heppner; MSP-1 Working Group: Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. Vaccine 24, 3009-3017 (2006)
136. Stoute, J. A., J. Gombe, M. R. Withers, J. Siangla, D. McKinney, M. Onyango, J. F. Cummings, J. Milman, K. Tucker, L. Soisson, V. A. Stewart, J. A. Lyon, E. Angov, A. Leach, J. Cohen, K. E. Kester, C. F. Ockenhouse, C. A. Holland, C. L. Diggs, J. Wittes & D. G. Heppner, the MSP-1 Malaria Vaccine Working Group: Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. Vaccine doi:10.1016/j. vaccine.2005.11.037 Epub ahead of print (2005)
137. Withers, M. R., D McKinney, BR Ogutu, JN Waitumbi, JB Milman, OJ Apollo, OG Allen, K Tucker, LA Soisson, C Diggs, A Leach, J Wittes, F Dubovsky, VA Stewart, SA Remich, J Cohen, WR Ballou, CA Holland, JA Lyon, E Angov, JA Stoute, SK Martin, DG Heppner for the Malaria Vaccine Working Group: Safety and reactogenicity of an MSP-1 malaria vaccine candidate: A randomized phase 1b dose-escalation trial in Kenyan Children. PLoS Clin Trials 1(7):e32. doi:10.1371/journal.pctr.0010032
138. Perlmann, H., K. Berzins, M. Wahlgren, J. Carlsson, A. Björkman, M. E. Patarroyo & P. Perlmann: Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med 159, 1686-1704 (1984) (Pubitemid 14117077)
139. Coppel, R. L., A. F. Cowman, R. F. Anders, A. E. Bianco, R. B. Saint, K. R. Lingelbach, D. J. Kemp & G. V. Brown. Immune sera recognize on erythrocytes a Plasmodium falciparum antigen composed of repeated amino acid sequences. Nature 310, 789-792 (1984) (Pubitemid 14057661)
140. Berzins, K., H. Perlmann, B. Wåhlin J. Carlsson, M. Wahlgren, R. Udomsangpetch, A. Björkman, M. E. Patarroyo & P. Perlmann: Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci USA 83:1065-1069 (1986) (Pubitemid 16086412)
141. Collins, W. E., R. F. Anders, M. Pappaioanou, G. H. Campbell, G. V. Brown, D. J. Kemp, R. L. Coppel, J. C. Skinner, P. M. Andrysiak, J. M. Favaloro, L. M. Corcoran, J. R. Broderson, G. F. Mitchell & C. C. Campbell: Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature 323, 259-262 (1986) (Pubitemid 16054311)
142. Collins, W. E., R. F. Anders, T. K. Ruebush, D. J. Kemp, G. C. Woodrow, G. H. Campbell, G. V. Brown, D. O. Irving, N. Goss, V. K. Filipski, R. L. Coppel, J. R. Broderson, L. M. Thomas, D. Pye, J. C. Skinner, C. Wilson, P. S. Stanfill & P. M. Procell: Immunization of owl monkeys with the ringinfected erythrocyte surface antigen of Plasmodium falciparum. Am J Trop Med Hyg 44, 34-41 (1991)
143. Pye, D., S. J. Edwards, R. F. Anders, C. M. O'Brien, P. Franchina, L. N. Corcoran, C. Monger, M. G. Peterson, K. L. Vandenberg, J. A. Smythe, S. R. Westley, R. L. Coppel, T. L. Webster, D. J. Kemp, A. W. Hampson & C. J. Langford: Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria. Infect Immun 59, 2403-2411 (1991)
144. Kulane, A., A. B. Siddique, H. Perlmann, N. Ahlborg, C. Roussilhon, A. Tall, A. Dieye, P. Perlmann & M. Troye-Blomberg: T-and B-cell responses of malaria immune individuals to synthetic peptides corresponding to nonrepeat sequences in the N-terminal region of the Plasmodium falciparum antigen Pf155/RESA. Acta Tropica 68, 37-51 (1997) (Pubitemid 27438297)
145. Al-Yaman, F., B. Genton, R. Anders, J. Taraika, M. Ginny, S. Mellor & M. P. Alpers: Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol 17, 493-501 (1995)
146. Al-Yaman, F., B. Genton, J. Taraika, R. Anders & M. P. Alpers: Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area. Parasite Immunol 19, 249-254 (1997) (Pubitemid 27293344)
147. Genton, B., I. Betuela, I. Felger, F. Al-Yaman, R. F. Anders, A. Saul, L. Rare, M. Baisor, K. Lorry, G. V. Brown, D. Pye, D. O. Irving, T. A. Smith, H.-P. Beck and M. P. Alpers: A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 185, 820-827 (2002) (Pubitemid 34226210)
148. Genton, B., F. Al-Yaman, I. Betuela, R. F. Anders, A. Saul, K. Baea, M. Mellombo, J. Taraika, G. V. Brown, D. Pye, D. O. Irving, I. Felger, H.-P. Beck, T. A. Smith & M. P. Alpers: Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children. Vaccine 22, 30-41 (2003) (Pubitemid 37357150)
149. Graves, P. & H. Gelband: Vaccines for preventing malaria (blood-stage). Cochrane Database Systematic Reviews, Cochrane Library, Vol. 4, 2006
150. Audran, R., M. Cachat, F. Lurati, S. Soe, O. Leroy, G. Corradin, P. Druilhe & F. Spertini: Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen. Infect Immun 73, 8017-8026 (2005) (Pubitemid 41740288)
151. Meraldi, V., I. Nebié, A. B. Tiono, D. Diallo, E. Sanogo, M. Theisen, P. Druilhe, G. Corradin, R. Moret & B. S. Sirima: Natural antibody responses to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol 26, 265-272 (2004) (Pubitemid 39576327)
152. Hisaeda, H., A. Saul, J. J. Reece, M. C. Kennedy, C. A. Long, L. H. Miller & A. W. Stowers: Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys. J Infect Dis 185, 657-664 (2002) (Pubitemid 34171471)
153. Druilhe, P., F. Spertini, D. Soesoe, G. Corradin, P. Mejia, S. Singh, R. Audran, A. Bouzidi, C. Oeuvray & C. Roussilhon: A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum. PLoS Medicine 2, 1135-1144 (2005) (Pubitemid 41735781)
154. Kaslow, D. C.: Transmission-blocking vaccines. Chem Immunol 80, 287-307 (2002) (Pubitemid 34516805)
155. Williamson, K. C.: Pfs230: from malaria transmissionblocking vaccine candidate toward function. Parasite Immunol 25, 351-359 (2003) (Pubitemid 38019278)
156. Mendis, K. N., Y. D. Munesinghe, Y. N. Y. De Silva, I. Keragalla & R. Carter: Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans. Infect Immun 55, 369-372 (1987) (Pubitemid 17004114)
157. Fujioka, H & M Aikawa: Structure and life cycle. In: Malaria immunology. Chem Immunol Vol. 80, Eds: Perlmann P, Troye-Blomberg M, Basel, Switzerland, Karger, 1-26 (2002) (Pubitemid 34516791)
158. van Dijk, M. R., C. J. Janse, J. Thompson, A. P. Waters, J. A. M. Braks, H. J. Dodemont, H. G. Stunnenberg, G.-J. van Gemert, R. W. Sauerwein & W. Eling: A central role for P48/45 in malaria parasite male gamete fertility. Cell 104, 153-164 (2001) (Pubitemid 32144980)
159. Eksi, S., B. Czesny, G.-J. van Gemert, R. W. Sauerwein, W. Eling & K. C. Williamson: Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production. Mol Microbiol 61, 991-998 (2006) (Pubitemid 44134175)
160. Tomas, A. M., G. Margos, G. Dimopoulos, L. H. M. van Lin, T. F. de Koning-Ward, R. Sinha, P. Lupetti, A. L. Beetsma, M. C. Rodriguez, M. Karras, A. Hager, J. Mendoza, G. A. Butcher, F. Kafatos, C. J. Janse, A. P. Waters & R. E. Sinden: P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. EMBO J 20, 3975-3983 (2001) (Pubitemid 32751814)
161. Kaslow, D. C.: Transmission-blocking vaccines. In: Malaria vaccine development: A multi-immune response approach Ed: Hoffman S, ASM Press, Washington, DC, 181-227 (1996)
162. Arakawa, T., A. Komesu, H. Otsuki, J. Sattabongkot, R. Udomsangpetch, Y. Matsumoto, N. Tsuji, Y. Wu, M. Torii & T. Tsuboi: Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. Infect Immun 73, 7375-7380 (2005) (Pubitemid 41587639)
163. Stowers, A. W., D. B. Keister, O. Muratova & D. C. Kaslow: A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies. Infect Immun 68, 5530-5538 (2000)
164. Schofield, L. & G. E. Grau: Immunological processes in malaria pathogenesis. Nat Rev Immunol 5, 722-735 (2005) (Pubitemid 43086173)
165. JHL Playfair: An antitoxic vaccine for malaria? In: Malaria vaccine development: A multi-immune response approach Ed: Hoffman SL, ASM Press, Washington, DC, 167-179 (1996)
166. Schofield, L.: Antidisease vaccines. Chem Immunol 80, 322-342 (2002) (Pubitemid 34516807)
167. CS Boutlis, EM Riley, NM Anstey & JB de Souza: Glycosylphosphatidylinositols in malaria pathogenesis and immunity: Potential for therapeutic intervention and vaccination. In: Immunology and immunopathogenesis of malaria. Curr Top Microbiol Immunol Vol. 297. Ed: Langhorne J, Springer-Verlag, Berlin, Germany 146-185 (2005)
168. Schofield, L., M. C. Hewitt, K. Evans, M.-A. Siomos & P. H. Seeberger: Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418, 785-789 (2002)
169. Bouharoun-Tayoun, H., C. Oeuvray, F. Lunel & P. Druilhe: Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 182, 409-418 (1995)
170. Brabin, B. J., C. Romagosa, S. Abdelgalil, C. Menéndez, F. H. Verhoeff, R. McGready, K. A. Fletcher, S. Owens, U. d'Allessandro, F. Nosten, P. R. Fischer & J. Ordi: The sick placenta-the role of malaria. Placenta 25, 359-378 (2004)
171. Beeson, J. G., J. C. Reeder, S. J. Rogerson & G. V. Brown: Parasite adhesion and immune evasion in placental malaria. Trends Parasitol 17, 331-337 (2001) (Pubitemid 32553750)
172. Rogerson, S. J., E. Pollina, A. Getachew, E. Tadesse, V. M. Lema & M. E. Molyneux: Placental monocyte infiltrates in response to Plasmodium falciparum infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg 68, 115-119 (2003) (Pubitemid 38234859)
173. Craig, A. & A. Scherf: Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol Biochem Parasitol 115, 129-143 (2001) (Pubitemid 32566223)
174. Salanti, A., T. Staalsoe, T. Lavstsen, A. T. R. Jensen, M. P. Kordai Sowa, D. E. Arnot, L. Hviid & T. G. Theander: Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 49, 179-191 (2003) (Pubitemid 36792013)
175. Duffy, M. F., A. G. Maier, T. J. Byrne, A. J. Marty, S. R. Elliott, M. T. O'Neill, P. D. Payne, S. J. Rogerson, A. F. Cowman, B. S. Crabb & G. V. Brown: VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol Biochem Parasitol [Epub ahead of print] doi:10.1016/j.molbiopara.2006.03.006 (2006) (Pubitemid 43946508)
176. Deitsch, K. W. & L. Hviid: Variant surface antigens, virulence genes and the pathogenesis of malaria. Trends Parasitol 20, 562-566 (2004) (Pubitemid 39446746)
177. Baruch, D. I., B. Gamain, J. W. Barnwell, J. S. Sullivan, A. Stowers, G. G. Galland, L. H. Miller & W. E. Collins: Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proc Natl Acad Sci 99, 3860-3865 (2002) (Pubitemid 34252196)
178. Snow, R. W., B. Nahlen, A. Palmer, C. A. Donnelly, S. Gupta & K. Marsh: Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. J Infect Dis 177, 819-822 (1998) (Pubitemid 28099909)
179. Riley, E. M., G. E. Wagner, M. F. Ofori, J. G. Wheeler, B. D. Akanmori, K. Tetteh, D. McGuinness, S. Bennett, F. K. Nkrumah, R. F. Anders & K. A. Koram: Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun 68, 5856-5863 (2000)
180. Riley, E. M., G. E. Wagner, B. D. Akanmori & K. A. Koram: Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol 23, 51-59 (2001) (Pubitemid 32231907)
181. King, C. L., I. Malhotra, A. Wamachi, J. Kioko, P. Mungai, S. A. Wahab, D. Koech, P. Zimmerman, J. Ouma & J. W. Kazura. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol 168, 356-364 (2002) (Pubitemid 34014137)
182. Zhou, Z., P. Schnake, L. Xiao & A. A. Lal: Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization. Protein Exp Purif 34, 87-94 (2004) (Pubitemid 38272316)
183. Tuteja, R.: DNA vaccine against malaria: A long way to go. Crit Rev Biochem Mol Biol 37, 29-54 (2002) (Pubitemid 34226171)
184. Doolan, D. L. and S. L. Hoffman: Nucleic acid vaccination against malaria. Chem Immunol 80, 308-321 (2002) (Pubitemid 34516806)
185. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery & M. A. Liu: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749 (1993) (Pubitemid 23114660)
186. Wang, R., D. L. Doolan, T. P. Le, R. C. Hedstrom, K. M. Coonan, Y. Charoenvit, T. R. Jones, P. Hobart, M. Margalith, J. Ng, W. R. Weiss, M. Sedegah, C. de Taisne, J. A. Norman & S. L. Hoffman: Induction of antigenspecific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-480 (1998) (Pubitemid 28483675)
187. + type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci USA 98, 10817-10822 (2001) (Pubitemid 32878703)
188. Bejon, P., J. Mwacharo, O. K. Kai, S. Todryk, S. Keating, T. Lang, S. C. Gilbert, N. Peshu, K. Marsh & A. V. S. Hill: Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area. Vaccine 24, 4709-4715 (2006) (Pubitemid 43776788)
189. Dunachie, S. J., & A. V. S. Hill. Prime-boost strategies for malaria vaccine development. J Exp Biol 206, 3771-3779 (2003) (Pubitemid 37365459)
190. Moore, A. C. & A. V. S. Hill: Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunol Rev 199, 126-143 (2004) (Pubitemid 38736768)
191. Gilbert, S. C., V. S. Moorthy, L. Andrews, A. A. Pathan, S. J. McConkey, J. M. Vuola, S. M. Keating, T. Berthoud, D. Webster, H. McShane & A. V. S. Hill: Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 24, 4554-4561 (2006) (Pubitemid 43776762)
192. Webster, D. P., S. Dunachie, J. M. Vuola, T. Berthoud, S. Keating, S. M. Laidlaw, S. J. McConkey, I. Poulton, L. Andrews, R. F. Andersen, P. Bejon, G. Butcher, R. Sinden, M. A. Skinner, S. C. Gilbert and A. V. S. Hill: Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci USA 102, 4836-4841 (2005) (Pubitemid 40471540)
193. Walther, M., F. M. Thompson, S. Dunachie, S. Keating, S. Todryk, T. Berthoud, L. Andrews, R. F. Andersen, A. Moore, S. C. Gilbert, I. Poulton, F. Dubovsky, E. Tierney, S. Correa, A. Huntcooke, G. Butcher, J. Williams, R. E. Sinden & A. V. S. Hill: Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein. Infect Immun 74, 2706-2716 (2006) (Pubitemid 43672979)
194. Prieur, E., S. G. Gilbert, J. Schneider, A. C. Moore, E. G. Sheu, N. Goonetilleke, K. J. H. Robson & A. V. S. Hill: A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses. Proc Natl Acad Sci USA 101, 290-295 (2004) (Pubitemid 38084243)
195. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, I. T. Paulsen, K. James, J. A. Eisen, K. Rutherford, S. L. Salzberg, A. Craig, S. Kyes, M.-S. Chan, V. Nene, S. J. Shallom, B. Suh, J. Peterson, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M. W. Mather, A. B. Vaidya, D. M. A. Martin, A. H. Fairlamb, M. J. Fraunholz, D. S. Roos, S. A. Ralph, G. I. McFadden, L. M. Cummings, G. M. Subramanian, C. Mungall, J. C. Venter, D. J. Carucci, S. L. Hoffman, C. Newbold, R. W. Davis, C. M. Fraser & B. Barrell: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511 (2002)
196. Carlton, J. M., S. V. Angiuoli, B. B. Suh, T. W. Kooij, M. Pertea, J. C. Silva, M. D. Ermolaeva, J. E. Allen, J. D. Selengut, H. L. Koo, J. D. Peterson, M. Pop, D. S. Kosack, M. F. Shumway, S. L. Bidwell, S. J. Shallom, S. E. van Aken, S. B. Riedmuller, T. V. Feldblyum, J. K. Cho, J. Quackenbush, M. Sedegah, A. Shoaibi, L. M. Cummings, L. Florens, J. R. Yates, J. D. Raine, R. E. Sinden, M. A. Harris, D. A. Cunningham, P. R. Preiser, L. W. Bergman, A. B. Vaidya, L. H. van Lin, C. J. Janse, A. P. Waters, H. O. Smith, O. R. White, S. L. Salzberg, J. C. Venter, C. M. Fraser, S. L. Hoffman, M. J. Gardner & D. J. Carucci: Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 419, 512-519 (2002)
197. PL Whetzel, SV Date, K Essien, MJ Fraunholz, B Gajria, GR Grant, J Iodice, JC Kissinger, PT Labo, AJ Milgram, CJ Stockert & DS Roos: PlasmoDB: The Plasmodium genome resource. In: Molecular approaches to malaria (Ed Sherman I. W.) ASM Press, Washington DC, 12-23 (2005)
198. Haddad, D., E. Bilcikova, A. A. Witney, J. M. Carlton, C. E. White, P. L. Blair, R. Chattopadhyay, J. Russell, E. Abot, Y. Charoenvit, J. C. Aguiar, D. J. Carucci & W. R. Weiss: Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect Immun 72, 1594-1602 (2004) (Pubitemid 38263782)
199. Doolan, D. L., S. Southwood, D. A. Freilich, J. Sidney, N. L. Graber, L. Shatney, L. Bebris, L. Florens, C. Dobano, A. A. Witney, E. Appella, S. L. Hoffmann, J. R. Yates, D. J. Carucci & A. Sette: Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci USA 100, 9952-9957 (2003). (Pubitemid 37087049)
200. Duffy, P. E., U. Krzych, S. Francis & M. Fried: Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum. Vaccine 23, 2235-2242 (2005) (Pubitemid 40341459)
201. Urban, B. C. & D. J. Roberts: Inhibition of T cell function during malaria: Implications for immunology and vaccinology. J Exp Med 197, 137-141 (2003) (Pubitemid 36152308)
202. Hisaeda, H., K. Yasutomo & K. Himeno: Malaria: immune evasion by parasites. Int J Biochem Cell Biol 37, 700-706 (2005) (Pubitemid 40202991)
203. Frevert, U: Sneaking in through the back entrance: the biology of malaria liver stages. Trends Parasitol 20, 417-424 (2004) (Pubitemid 39485676)
204. Angus, B. J., K. Chotivanich, R. Udomsangpetch & N. J. White: In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 90, 2037-2040 (1997) (Pubitemid 27377317)
205. Chotivanich, K., R. Udomsangpetch, A. Dondorp, T. Williams, B. Angus, J. A. Simpson, S. Pukrittayakamee, S. Looareesuwan, C. I. Newbold & N. J. White: The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis 182, 629-633 (2000) (Pubitemid 30651065)
206. Chotivanich, K., R. Udomsangpetch, R. McGready, S. Proux, P. Newton, S. Pukrittayakamee, S. Looareesuwan & N. J. White: Central role of the spleen in malaria parasite clearance. J Infect Dis 185, 1538-1541 (2002) (Pubitemid 34507982)
207. Millington, O. R., C. Di Lorenzo, R. S. Phillips, P. Garside & J. M. Brewer: Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol 5, 5.1-5.22 (2006)
208. Urban, B. C., D. J. P. Ferguson, A. Pain, N. Willcox, M. Plebanski, J. M. Austyn & D. J. Roberts: Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400, 73-77 (1999) (Pubitemid 29315113)
209. Steers, N., R. Schwenk, D. J. Bacon, D. Berenzon, J. Williams & U. Krzych: The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites. Eur J Immunol 35, 2335-2346 (2005) (Pubitemid 41179754)
210. Frevert, U., M. R. Galinski, F.-U. Hügel, N. Allon, H. Schrier, S. Smulevitch, M. Shakibaei & P. Clavijo: Malaria circumsporozoite protein inhibits protein synthesis in mammalian cells. EMBO J 17, 3816-3826 (1998) (Pubitemid 28333968)
211. Gilbert, S. C., M. Plebanski, S. Gupta, J. Morris, M. Cox, M. Aidoo, D. Kwiatkowski, B. M. Greenwood, H. C. Whittle & A. V. S. Hill: Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279, 1173-1177 (1998) (Pubitemid 28164361)
212. Plebanski, M., E. A. M. Lee, C. M. Hannan, K. L. Flanagan, S. C. Gilbert, M. B. Gravenor & A. V. S. Hill: Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming. Nat Med 5, 565-571 (1999) (Pubitemid 29220217)
213. Guevara Patiño, J. A., A. A. Holder, J. S. McBride & M. J. Blackman: Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J Exp Med 186, 1689-1699 (1997) (Pubitemid 27506282)
214. Omer, F. M., J. B. de Souza, P. H. Corran, A. A. Sultan & E. M. Riley: Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule. J Exp Med 198, 1817-1827 (2003) (Pubitemid 38032115)
215. Xu, X., K. Sumita, C. Feng, X. Xiong, H. Shen, S. Maruyama, M. Kanoh & Y. Asano: Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice. J Immunol 167, 235-241 (2001) (Pubitemid 32567783)
216. Walther, M., J. E. Tongren, L. Andrews, D. Korbel, E. King, H. Fletcher, R. F. Andersen, P. Bejon, F. Thompson, S. J. Dunachie, F. Edele, J. B. de Souza, R. E. Sinden, S. C. Gilbert, E. M. Riley & A. V. S. Hill: Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 23, 287-296 (2005) (Pubitemid 41317796)
217. Del Portillo, H. A., M. Lanzer, S. Rodriguez-Malaga, F. Zavala & C. Fernandez-Becerra: Variant genes and the spleen in Plasmodium vivax malaria. Int J Parasitol 34, 1547-1554 (2004)
218. Stubbs, J., K. M. Simpson, T. Triglia, D. Plouffe, C. J. Tonkin, M. T. Duraisingh, A. G. Maier, E. A. Winzeler & A. F. Cowman: Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309, 1384-1387 (2005) (Pubitemid 41209367)
219. Lüder, C. G. K., U. Gross & M. F. Lopes: Intracellular protozoan parasites and apoptosis: diverse strategies to modulate parasite-host interactions. Trends Parasitol 17, 480-486 (2001) (Pubitemid 32918267)
220. van de Sand, C., S. Horstmann, A. Schmidt, A. Sturm, S. Bolte, A. Krueger, M. Lütgehetmann, J.-M. Pollok, C. Libert & V. T. Heussler: The liver stage of Plasmodium berghei inhibits host cell apoptosis. Mol Microbiol 58, 731-742 (2005) (Pubitemid 41532471)
221. Leiriao, P., M. M. Mota & A. Rodriguez: Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. J Infect Dis 191, 1576-1581 (2005) (Pubitemid 40656744)
222. Helmby, H., G. Jönsson & M. Troye-Blomberg: Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect Immun 68, 1485-1490 (2000) (Pubitemid 30108548)
223. Xu, H., J. Wipasa, H. Yan, M. Zeng, M. O. Makobongo, F. D. Finkelman, A. Kelso & M. F. Good: The mechanism and significance of deletion of parasite-specific CD4+ T cells in malaria infection. J Exp Med 195, 881-892 (2002) (Pubitemid 34286759)
224. Riccio, E. K. P., I. N. Júnior, L. R. Pratt Riccio, M. das Graças Alecrim, S. Corte-Real, M. Morgado, C. T. Daniel-Ribeiro & M. de Fátima Ferreira-da-Cruz: Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks. Parasitol Res 90, 9-18 (2003) (Pubitemid 36577865)
225. Good, M. F., D. Stanisic, H. Xu, S. Elliott & M. Wykes: The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Immunol Rev 201, 254-267 (2004) (Pubitemid 39318457)
226. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller & K. Moudgil: Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11, 729-766 (1993) (Pubitemid 23115022)
227. Amante F. H., P. E. Crewther, R. F. Anders & M. F. Good: A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design. J Immunol 159, 5535-5544 (1997) (Pubitemid 127470082)
228. Gandon, S., M. J. Mackinnon, S. Nee & A. F. Read: Imperfect vaccines and the evolution of pathogen virulence. Nature 414, 751-756 (2001) (Pubitemid 34000772)
229. Mackinnon, M. J. & A. F. Read: Immunity promotes virulence evolution in a malaria model. PLoS Biology 2, 1286-1292 (2004)
230. S. L. Hoffman, & L. H. Miller: Perspectives on malaria vaccine development. In: Malaria vaccine development: A multi-immune response approach Ed: Hoffman SL, ASM Press, Washington, DC 1-13 (1996)
231. Müller, O., C. Traoré, B. Kouyaté, Y. Yé, C. Frey, B. Coulibaly & H. Becher: Effects of insecticide-treated bednets during early infancy in an African area of intense malaria transmission: a randomized controlled trial. Bull WHO 84, 120-126 (2006) (Pubitemid 43275769)
232. Artavanis-Tsakonas, K., J. E. Tongren & E. M. Riley: The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 133, 145-152 (2003) (Pubitemid 36918587)
233. Perkins, D. J., J. B. Weinberg & P. G. Kremsner: Reduced interleukin-12 and transforming growth factorbeta 1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis 182, 988-992 (2000)
234. Hirunpetcharat, C., F. Finkelman, I. A. Clark & M. F. Good: Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease. Parasite Immunol 21, 319-329 (1999) (Pubitemid 29257760)
235. Hafalla, J. C. R., I. A. Cockburn & F. Zavala: Protective and pathogenic roles of CD8+ T cells during malaria infection. Parasite Immunol 28, 15-24 (2006)
236. Rogers, W. O., F. Atuguba, A. R. Oduro, A. Hodgson & K. A. Koram: Clinical case definitions and malaria vaccine efficacy. J Infect Dis 193, 467-473 (2006) (Pubitemid 43122349)
237. Ohrt, C., M. Purnomo, M. A. Sutamihardja, D. Tang, and K. C. Kain: Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis 186, 540-546 (2002) (Pubitemid 34876264)